Project Details
Description
We will utilize genome sequencing to identify the genetic causes of primary and acquired resistance of Merkel cell carcinomas to immunotherapy.
Status | Finished |
---|---|
Effective start/end date | 7/1/19 → 6/30/21 |
Funding
- National Comprehensive Cancer Network (Agmt 6/24/19)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.